Middle East And Africa Remote Patient Monitoring And Care Market
Taille du marché en milliards USD
TCAC : %
Période de prévision |
2024 –2030 |
Taille du marché (année de référence) |
|
Taille du marché (année de prévision) |
Dollars américains 771.02 |
TCAC |
|
Principaux acteurs du marché |
>Marché de la surveillance et des soins à distance des patients au Moyen-Orient et en Afrique, par type d'appareil (appareils de surveillance cardiaque, appareils de surveillance de la pression artérielle, appareils de surveillance de la glycémie, appareils de surveillance respiratoire, appareils de surveillance neurologique, appareils de surveillance multiparamétrique et autres), application (oncologie, diabète, maladies cardiovasculaires et autres), utilisateur final (patients hospitalisés, patients ambulatoires et patients recevant des soins à domicile) - Tendances et prévisions de l'industrie jusqu'en 2030.
Analyse et perspectives du marché de la surveillance et des soins à distance des patients au Moyen-Orient et en Afrique
L'approche RPM et soins en matière de prestation de soins de santé est devenue de plus en plus populaire ces dernières années, notamment en raison de la pandémie de COVID-19, qui a entraîné une demande accrue d'options de soins à distance. La sensibilisation croissante à la RPM et aux soins à l'échelle mondiale a renforcé la demande pour le marché. L'augmentation des dépenses de santé pour de meilleurs services de santé contribue également à la croissance du marché. Les principaux acteurs du marché se concentrent sur divers lancements et approbations de services pendant cette période cruciale. En outre, l'augmentation des progrès technologiques améliorés des appareils contribue également à la demande croissante de RPM et de soins.
Le marché de la surveillance et des soins à distance des patients au Moyen-Orient et en Afrique devrait croître au cours de l'année de prévision en raison de l'augmentation du nombre d'acteurs sur le marché et de la disponibilité d'appareils de surveillance à distance avancés. Parallèlement à cela, les fabricants sont engagés dans l'activité de développement pour lancer de nouveaux appareils et des produits RPM efficaces et précis sur le marché. Le développement croissant dans le domaine des techniques de soins de santé avancées stimule encore la croissance du marché. Cependant, des difficultés telles que les réglementations strictes pour la production et la commercialisation de RPM et de produits de soins devraient freiner la croissance du marché au cours de la période de prévision.
L'augmentation des dépenses consacrées au développement et à l'avancement des soins de santé devrait offrir des opportunités de croissance du marché. Cependant, le coût élevé des dispositifs de surveillance et de soins à distance devrait constituer un défi à la croissance du marché.
Diverses entreprises prennent des initiatives qui conduisent progressivement à une croissance du marché.
Par exemple,
- En janvier 2023, CoachCare a annoncé l'acquisition de la société RPM NVOLVE, basée à Winston-Salem, afin d'étendre son expertise RPM dans le domaine de la douleur, de la colonne vertébrale et de l'orthopédie. Cette acquisition aiderait l'entreprise dans son portefeuille de produits et son expansion commerciale.
Data Bridge Market Research analyse que le marché de la surveillance et des soins à distance des patients au Moyen-Orient et en Afrique devrait atteindre la valeur de 771,02 millions USD d'ici 2030, à un TCAC de 6,9 % au cours de la période de prévision 2023-2030.
Rapport métrique |
Détails |
Période de prévision |
2023 à 2030 |
Année de base |
2022 |
Année historique |
2021 (personnalisable de 2015 à 2020) |
Unités quantitatives |
Chiffre d'affaires en millions USD |
Segments couverts |
Device Type (Cardiac Monitoring Devices, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices, Respiratory Monitoring Devices, Neurological Monitoring Devices, Multi-Parameter Monitoring Devices, and Others), Application (Oncology, Diabetes, Cardiovascular Diseases, and Others), End User (Hospital-Based Patients, Ambulatory Patients, and Home Healthcare Patients) |
Countries Covered |
South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa |
Market Players Covered |
Medtronic, Boston Scientific Corporation, VitalConnect, Biobeat, General Electric, Koninklijke Philips N.V., OMRON Corporation, Abbott, Nihon Kohden Corporation, Vivify Health, Inc., Aerotel Medical Systems, BIOTRONIK SE & Co. KG, A&D Company, Limited, AliveCor, Inc., Masimo, Dexcom, Inc., Senseonics, Inc., ResMed, 100Plus., ChroniSense Medical, Ltd., Vitls, cardiomo, CoachCare, neteera, and Withings among others |
Market Definition
Remote Patient Monitoring (RPM) and care is a healthcare delivery model that allows healthcare providers to monitor patients remotely, using various technological devices and communication tools, without the need for face-to-face visits. This approach enables healthcare providers to deliver care and track patient health data from a distance, often in real time.
RPM typically involves the use of sensors-enabled wearable devices and other technological devices that can track a patient's vital signs, medication adherence, physical activity, and other health-related information. The collected data is then transmitted to healthcare providers who can analyze the information and take appropriate action, such as adjusting medication dosages, providing guidance on lifestyle changes, or scheduling follow-up appointments.
Middle East and Africa Remote Patient Monitoring and Care Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Driver
- Increasing Prevalence of Chronic Diseases
The market is expanding due to various causes, including the increasing prevalence of chronic diseases. Chronic diseases are non-communicable illnesses that last long and necessitate continuing medical care and management.
According to the World Health Organization, chronic diseases account for nearly 70% of all deaths worldwide, with cardiovascular disease being the primary cause. The rising prevalence of chronic diseases is increasing due to many variables, including an aging population, sedentary lifestyles, poor nutrition, and environmental factors. RPM and care can help healthcare providers to manage chronic diseases more efficiently and effectively.
As a result of the sedentary lifestyle of people, the prevalence of lifestyle-associated disorders such as hypertension and diabetes witnessed a rise. Thus, the rising prevalence of chronic diseases with the growing integration of healthcare data with portable devices is expected to demand proper health management, leading to the anticipated increasing demand for RPM and care in the market in the forecast period.
Restraint
- Strict Regulatory Framework
Regulatory bodies play a critical role in ensuring that remote patient monitoring technologies meet safety and quality standards and protect patient privacy. However, regulatory compliance can be a significant barrier to entry for many companies and may slow down the adoption of remote patient monitoring technologies.
The medical device regulations hold significant responsibility for safeguarding the health of the people in the medical device industry itself. The regulations require manufacturers to inculcate quality systems (based on internationally accepted standards for quality systems) into the design process for class III and IV devices. They also require manufacturers to incorporate them into the manufacturing process for class II, III, and IV devices.
Along with such strict regulations of medical devices, it has also been reported that Health Canada’s decision related to medical device applications is not timely. It involves reviewing the submission of scientific evidence by manufacturers to ensure the efficacy of various devices.
This suggests that such a tedious procedure led to the development of other technologically advanced devices and hence, poses a big challenge in front of device manufacturers in submitting the approval documentation.
The regulations imposed would delay the supply of the instrumentation and long-time approval for the devices. This factor is expected to act as a restraint for market growth.
Opportunity
-
Strategic Initiatives by Market Players
The strategic initiatives taken by the key market players have helped in the rise in technologies and advancements in remote patient monitoring products and devices. They are taking initiatives such as product launches, collaborations, mergers, and acquisitions among others, which is expected to create more opportunities for market growth.
Healthcare product suppliers have a huge opportunity to work with new technology firms to ensure the industry's continued growth, creativity, and viability.
To discover and develop advanced remote monitoring facilities, companies are launching new initiatives and collaborating with other key players to deliver more reliable results and services.
These strategic initiatives such as product launches, approvals, acquisitions, and mergers done by major companies in the market have opened up an opportunity for companies in various regions. This strategy is allowing the companies to strengthen their footprints in the market. Therefore, it is predicted that strategic initiative is expected to provide an opportunity for market growth.
Challenge
- Lack of Skilled Professionals
Remote patient monitoring requires a range of professionals with specialized knowledge and expertise, including clinicians, technicians, and data analysts.
Clinicians are responsible for monitoring patient's health remotely and interpreting the data collected by remote patient monitoring devices.
Moreover, technicians are responsible for installing, maintaining, and troubleshooting remote patient monitoring devices. Data analysts are responsible for analyzing the data collected by remote patient monitoring devices and providing insights to healthcare providers. However, there is currently a shortage of data analysts, clinicians, and technicians with the necessary skills and experience to provide meaningful insights from remote patient monitoring data.
The lack of skilled professionals can also limit the adoption of RPM technologies and limit their potential to improve healthcare outcomes. Without skilled professionals, healthcare providers may struggle to interpret patient data and provide appropriate interventions, limiting the effectiveness of RPM in improving patient outcomes. Thus, the lack of skilled professionals is a significant factor expected to pose a challenge to market growth.
Recent Developments
- In January 2023, Masimo and Philips announced an expansion of their partnership to augment patient monitoring capabilities in home telehealth applications with the Masimo W1 advanced health tracking watch. This collaboration extension would help the company in remote patient monitoring product portfolio expansion.
- In December 2022, Masimo announced the full market release of the Hydration Index (Hi) for the Masimo W1 watch. The Masimo W1, an advanced health-tracking wearable, is the first watch to offer accurate, continuous pulse oximetry measurements and insightful health data, from the leader in hospital pulse oximetry. This product upgradation would help the company in product business expansion.
Middle East and Africa Remote Patient Monitoring and Care Market Scope
The Middle East and Africa remote patient monitoring and care market is segmented into three notable segments such as device type, application, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Device Type
- Cardiac Monitoring Devices
- Blood Pressure Monitoring Devices
- Blood Glucose Monitoring Devices
- Respiratory Monitoring Devices
- Neurologiocal Monitoring Devices
- Multi-Parameter Monitoring Devices
- Others
On the basis of device type, the market is segmented into cardiac monitoring devices, blood pressure monitoring devices, blood glucose monitoring devices, respiratory monitoring devices, neurological monitoring devices, multi-parameter monitoring devices, and others.
Application
- Oncology
- Diabetes
- Cardiovascular Diseases
- Others
On the basis of application, the market is segmented into oncology, diabetes, cardiovascular diseases, and others.
End User
- Hospital-Based Patients
- Ambulatory Patients
- Home healthcare patients
On the basis of end user, the market is segmented into hospital-based patients, ambulatory patients, and home healthcare patients.
Middle East and Africa Remote Patient Monitoring and Care Market Regional Analysis/Insights
The Middle East and Africa remote patient monitoring and care market is segmented into three notable segments such as device type, application, and end user.
The countries covered in this market report are South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa.
South Africa is expected to dominate the Middle East and Africa remote patient monitoring and care market due to the increasing customer inclinations towards advanced technological processes.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Middle East and Africa Remote Patient Monitoring and Care Market Share Analysis
The Middle East and Africa remote patient monitoring and care market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
Certains des principaux acteurs du marché opérant sur le marché de la surveillance et des soins à distance des patients au Moyen-Orient et en Afrique sont Medtronic, Boston Scientific Corporation, VitalConnect, Biobeat, General Electric, Koninklijke Philips NV, OMRON Corporation, Abbott, Nihon Kohden Corporation, Vivify Health, Inc., Aerotel Medical Systems, BIOTRONIK SE & Co. KG, A&D Company, Limited, AliveCor, Inc., Masimo, Dexcom, Inc., Senseonics, Inc., ResMed, 100Plus., ChroniSense Medical, Ltd., Vitls, cardiomo, CoachCare, neteera et Withings, entre autres.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 CARDIAC MONITORING DEVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 VALUE CHAIN ANALYSIS:
4.3 COMPETITIVE ANALYSIS
4.4 BRAND ANALYSIS
4.5 ECOSYSTEM MAPS
4.6 TECHNOLOGICAL TRENDS
4.7 TOP WINNING STRATEGIES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
5.1.2 GROWTH IN TECHNOLOGICAL ADVANCEMENTS
5.1.3 INCREASING DEMAND FOR REMOTE PATIENT MONITORING
5.1.4 INCREASING GOVERNMENT INITIATIVES
5.2 RESTRAINTS
5.2.1 STRICT REGULATORY FRAMEWORK
5.2.2 LACK OF STANDARDIZATION
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
5.3.2 PROVIDES QUICK AND REAL TIME RESULTS
5.4 CHALLENGES
5.4.1 LACK OF SKILLED PROFESSIONALS
5.4.2 RISK TO PATIENT'S DATA SECURITY
6 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE
6.1 OVERVIEW
6.2 CARDIAC MONITORING DEVICES
6.3 BLOOD PRESSURE MONITORING DEVICES
6.4 MULTI-PARAMETER MONITORING DEVICES
6.5 BLOOD GLUCOSE MONITORING DEVICES
6.6 RESPIRATORY MONITORING DEVICES
6.7 NEUROLOGICAL MONITORING DEVICES
6.8 OTHERS
7 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 CARDIOVASCULAR DISEASE
7.2.1 CORONARY HEART DISEASE
7.2.2 STROKE
7.2.3 PERIPHERAL ARTERIAL DISEASE
7.2.4 AORTIC DISEASE
7.2.5 OTHERS
7.3 DIABETES
7.4 ONCOLOGY
7.5 OTHERS
8 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER
8.1 OVERVIEW
8.2 HOME HEALTHCARE PATIENTS
8.2.1 BLOOD GLUCOSE MONITORING DEVICES
8.2.2 CARDIAC MONITORING DEVICES
8.2.3 BLOOD PRESSURE MONITORING DEVICES
8.2.4 MULTI-PARAMETER MONITORING DEVICES
8.2.5 RESPIRATORY MONITORING DEVICES
8.2.6 NEUROLOGICAL MONITORING DEVICES
8.2.7 OTHERS
8.3 AMBULATORY PATIENTS
8.3.1 MULTI-PARAMETER MONITORING DEVICES
8.3.2 RESPIRATORY MONITORING DEVICES
8.3.3 CARDIAC MONITORING DEVICES
8.3.4 BLOOD PRESSURE MONITORING DEVICES
8.3.5 BLOOD GLUCOSE MONITORING DEVICES
8.3.6 NEUROLOGICAL MONITORING DEVICES
8.3.7 OTHERS
8.4 HOSPITAL-BASED PATIENTS
8.4.1 MULTI-PARAMETER MONITORING DEVICES
8.4.2 CARDIAC MONITORING DEVICES
8.4.3 RESPIRATORY MONITORING DEVICES
8.4.4 BLOOD PRESSURE MONITORING DEVICES
8.4.5 BLOOD GLUCOSE MONITORING DEVICES
8.4.6 NEUROLOGICAL MONITORING DEVICES
8.4.7 OTHERS
9 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION
9.1 MIDDLE EAST AND AFRICA
9.1.1 SOUTH AFRICA
9.1.2 EGYPT
9.1.3 ISRAEL
9.1.4 UAE
9.1.5 SAUDI ARABIA
9.1.6 REST OF MIDDLE EAST AND AFRICA
10 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 MEDTRONIC
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 DEXCOM, INC.
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 ABBOTT
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 RESMED
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 BIOTRONIK SE & CO. KG
12.5.1 COMPANY SNAPSHOT
12.5.2 COMPANY SHARE ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 RECENT DEVELOPMENT
12.6 100 PLUS.
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
12.7 A&D COMPANY, LIMITED
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 COMPANY SHARE ANALYSIS
12.7.4 PRODUCT PORTFOLIO
12.7.5 RECENT DEVELOPMENT
12.8 AEROTEL MEDICAL SYSTEMS
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 ALIVECOR, INC.
12.9.1 COMPANY SNAPSHOT
12.9.2 COMPANY SHARE ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENTS
12.1 BIOBEAT
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
12.11 BOSTON SCIENTIFIC CORPORATION
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 COMPANY SHARE ANALYSIS
12.11.4 PRODUCT PORTFOLIO
12.11.5 RECENT DEVELOPMENT
12.12 CARDIOMO
12.12.1 COMPANY SNAPSHOT
12.12.2 PRODUCT PORTFOLIO
12.12.3 RECENT DEVELOPMENTS
12.13 CHRONISENSE MEDICAL, LTD.
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENT
12.14 COACHCARE
12.14.1 COMPANY SNAPSHOT
12.14.2 PRODUCT PORTFOLIO
12.14.3 RECENT DEVELOPMENT
12.15 GENERAL ELECTRIC
12.15.1 COMPANY SNAPSHOT
12.15.2 REVENUE ANALYSIS
12.15.3 COMPANY SHARE ANALYSIS
12.15.4 PRODUCT PORTFOLIO
12.15.5 RECENT DEVELOPMENT
12.16 KONINKLIJKE PHILIPS N.V.
12.16.1 COMPANY SNAPSHOT
12.16.2 REVENUE ANALYSIS
12.16.3 COMPANY SHARE ANALYSIS
12.16.4 PRODUCT PORTFOLIO
12.16.5 RECENT DEVELOPMENT
12.17 MASIMO
12.17.1 COMPANY SNAPSHOT
12.17.2 REVENUE ANALYSIS
12.17.3 COMPANY SHARE ANALYSIS
12.17.4 PRODUCT PORTFOLIO
12.17.5 RECENT DEVELOPMENT
12.18 NETEERA
12.18.1 COMPANY SNAPSHOT
12.18.2 PRODUCT PORTFOLIO
12.18.3 RECENT DEVELOPMENT
12.19 NIHON KOHDEN CORPORATION
12.19.1 COMPANY SNAPSHOT
12.19.2 REVENUE ANALYSIS
12.19.3 COMPANY SHARE ANALYSIS
12.19.4 PRODUCT PORTFOLIO
12.19.5 RECENT DEVELOPMENT
12.2 OMRON CORPORATION
12.20.1 COMPANY SNAPSHOT
12.20.2 REVENUE ANALYSIS
12.20.3 COMPANY SHARE ANALYSIS
12.20.4 PRODUCT PORTFOLIO
12.20.5 RECENT DEVELOPMENT
12.21 SENSEONICS, INC.
12.21.1 COMPANY SNAPSHOT
12.21.2 REVENUE ANALYSIS
12.21.3 COMPANY SHARE ANALYSIS
12.21.4 PRODUCT PORTFOLIO
12.21.5 RECENT DEVELOPMENT
12.22 VITALCONNECT
12.22.1 COMPANY SNAPSHOT
12.22.2 PRODUCT PORTFOLIO
12.22.3 RECENT DEVELOPMENT
12.23 VITLS
12.23.1 COMPANY SNAPSHOT
12.23.2 PRODUCT PORTFOLIO
12.23.3 RECENT DEVELOPMENT
12.24 VIVIFY HEALTH INC.
12.24.1 COMPANY SNAPSHOT
12.24.2 PRODUCT PORTFOLIO
12.24.3 RECENT DEVELOPMENTS
12.25 WITHINGS
12.25.1 COMPANY SNAPSHOT
12.25.2 COMPANY SHARE ANALYSIS
12.25.3 PRODUCT PORTFOLIO
12.25.4 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS
Liste des tableaux
TABLE 1 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA CARDIAC MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA BLOOD PRESSURE MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA MULTI-PARAMETER MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA RESPIRATORY MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA NEUROLOGICAL MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA OTHERS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA CARDIOVASCULAR DISEASE IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA CARDIOVASCULAR DISEASE IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA DIABETES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA ONCOLOGY IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA OTHERS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 30 SOUTH AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 31 SOUTH AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 32 SOUTH AFRICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 33 SOUTH AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 34 SOUTH AFRICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 35 SOUTH AFRICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 36 SOUTH AFRICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 37 EGYPT REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 38 EGYPT REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 39 EGYPT CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 40 EGYPT REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 41 EGYPT HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 42 EGYPT AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 43 EGYPT HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 44 ISRAEL REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 45 ISRAEL REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 46 ISRAEL CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 47 ISRAEL REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 48 ISRAEL HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 49 ISRAEL AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 50 ISRAEL HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 51 UAE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 52 UAE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 53 UAE CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 54 UAE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 55 UAE HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 56 UAE AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 57 UAE HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 58 SAUDI ARABIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 59 SAUDI ARABIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 60 SAUDI ARABIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 61 SAUDI ARABIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 62 SAUDI ARABIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 63 SAUDI ARABIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 64 SAUDI ARABIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 65 REST OF MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
Liste des figures
FIGURE 1 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET IN THE FORECAST PERIOD
FIGURE 12 THE CARDIAC MONITORING DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET
FIGURE 14 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, 2022
FIGURE 15 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, 2023-2030 (USD MILLION)
FIGURE 16 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, CAGR (2023-2030)
FIGURE 17 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, 2022
FIGURE 19 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 21 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, 2022
FIGURE 23 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 24 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 25 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, LIFELINE CURVE
FIGURE 26 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 27 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022)
FIGURE 28 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 29 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 30 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: DEVICE TYPE (2023-2030)
FIGURE 31 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY SHARE 2022 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.